common challenges glp-1 users Receptor Agonists GLP-1 medications get at the
Description
A systematic review pooling data from 27,617 patients found that semaglutide use lowered MACE risk by 19% overall (RR 0.81)
GLP-1s can lead to significant weight lossup to 22.5% of body weight
Small adjustments to your routine, like where you inject and how you prepare the skin beforehand, can make each dose noticeably more comfortable over time
Ask about the weight management program first
Schedule regular visits to assess GI symptoms, nutritional intake, weight trends, and medication adherence
Contributing: Naledi Ushe
